Sainef Therapeutics Private Limited
About Sainef Therapeutics Private Limited
Data last updated:
Sainef Therapeutics Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 May 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U46497DL2023PTC450624.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Suresh Kumar Sahoo (Managing Director) and Srinibas Sahoo.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 11 3rd Floor Block B, Mayapuri Industrial Area Phase I, New Delhi, Delhi, India – 110064.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.18 Cr, a growth of 109% compared to the previous year. For the same year it recorded a net profit of ₹27.22 Lakh (net margin 3.8%) and EBITDA of ₹37.83 Lakh (EBITDA margin 5.3%).
Company details
CIN history
Sainef Therapeutics has one previous CIN (Corporate Identification Number): U46497OD2023PTC042611. The current CIN is U46497DL2023PTC450624, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U46497DL2023PTC450624 | Current |
| U46497OD2023PTC042611 | Previous |
Contact details
Sainef Therapeutics Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressB – 11 3rd Floor Block B, Mayapuri Industrial Area Phase I, New Delhi, Delhi, India – 110064
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sainef Therapeutics is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Sainef Therapeutics Private Limited, buy the company report.
Financials of Sainef Therapeutics Private Limited
FY 2025 filings availableSainef Therapeutics Private Limited reported revenue of ₹7.18 Cr (up 109% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 109% in the latest year. EBITDA rose 41% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹37.83 Lakh | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹27.22 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 5.3% | |
| Net Profit Margin | 3.8% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Sainef Therapeutics Private Limited, buy the company report.
Board of directors of Sainef Therapeutics Private Limited
Sainef Therapeutics has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinibas Sahoo | Director | 11 May 2023 | 3 Years 5 Months | Current |
| Suresh Kumar Sahoo | Managing Director | 11 May 2023 | 3 Years 5 Months | Current |
Legal cases
No court or tribunal cases involving Sainef Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sainef Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sainef Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sainef Therapeutics Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Srinibas Sahoo was appointed as Director on 11 May 2023.
Frequently asked questions
Sainef Therapeutics is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 May 2023 (3+ years old) and is registered under CIN U46497DL2023PTC450624.
Sainef Therapeutics has 2 current directors:
- Suresh Kumar Sahoo - Managing Director
- Srinibas Sahoo - Director
The latest financial statements of Sainef Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Sainef Therapeutics is U46497DL2023PTC450624. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sainef Therapeutics was incorporated on 11 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
Srinibas Sahoo was appointed as Director on 11 May 2023. Suresh Kumar Sahoo was appointed as Managing Director on 11 May 2023.
The registered office of Sainef Therapeutics is at B – 11 3rd Floor Block B, Mayapuri Industrial Area Phase I, New Delhi, Delhi, India – 110064.
Sainef Therapeutics operates in the pharma industry, in the drug formulation and development segment.
Sainef Therapeutics can be reached at its registered office: B – 11 3rd Floor Block B, Mayapuri Industrial Area Phase I, New Delhi, Delhi, India – 110064.
Sainef Therapeutics is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
